Related Experiment Video
Updated: Jul 1, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
METTL3 as a master regulator of translation in cancer: mechanisms and implications
Margalida Esteva-Socias1,2, Francesca Aguilo1,2
1Department of Molecular Biology, Umeå University, SE-901 85Umeå, Sweden.
Abstract:
Translational regulation is an important step in the control of gene expression. In cancer cells, the orchestration of both global control of protein synthesis and selective translation of specific mRNAs promote tumor cell survival, angiogenesis, transformation, invasion and metastasis. N6-methyladenosine (m6A), the most prevalent mRNA modification in higher eukaryotes, impacts protein translation. Over the past decade, the development of m6A mapping tools has facilitated comprehensive functional investigations, revealing the involvement of this chemical mark, together with its writer METTL3, in promoting the translation of both oncogenes and tumor suppressor transcripts, with the impact being context-dependent. This review aims to consolidate our current understanding of how m6A and METTL3 shape translation regulation in the realm of cancer biology. In addition, it delves into the role of cytoplasmic METTL3 in protein synthesis, operating independently of its catalytic activity. Ultimately, our goal is to provide critical insights into the interplay between m6A, METTL3 and translational regulation in cancer, offering a deeper comprehension of the mechanisms sustaining tumorigenesis.
Insights
N6-methyladenosine (m6A) and its writer METTL3 regulate protein translation in cancer. This review explores how m6A and METTL3 impact cancer cell survival and metastasis.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- Gene expression control is crucial in cancer.
- Translational regulation impacts tumor progression.
- N6-methyladenosine (m6A) is a key mRNA modification affecting translation.
Purpose of the Study:
- To review the role of m6A and METTL3 in cancer translational regulation.
- To explore the impact of m6A and METTL3 on oncogenes and tumor suppressors.
- To discuss cytoplasmic METTL3's role in protein synthesis.
Main Methods:
- Literature review of m6A mapping tools and functional investigations.
- Analysis of m6A and METTL3 involvement in cancer-related gene translation.
- Examination of METTL3's catalytic-independent functions.
Main Results:
- m6A and METTL3 influence the translation of both oncogenes and tumor suppressor genes.
- The effect of m6A modification is context-dependent in cancer.
- Cytoplasmic METTL3 participates in protein synthesis independently of its enzymatic activity.
Conclusions:
- m6A and METTL3 are critical regulators of translational control in cancer.
- Understanding this interplay provides insights into tumorigenesis mechanisms.
- Targeting m6A and METTL3 pathways may offer therapeutic strategies.
Related Concept Videos
Master Transcription Regulators
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression at Multiple Steps
Regulated mRNA Transport
PI3K/mTOR/AKT Signaling Pathway

